Meridian.

A portfolio across therapeutic areas

Medicines for the conditions that matter most

Meridian Therapeutics researches and develops targeted medicines across oncology, neuroscience, cardiology, hematology and rare disease.

Explore our portfolio Ask Medical Information →

Our portfolio

Targeted medicines, across areas of need

Ask Medical Information about any medicine in our portfolio — the assistant shares general, source-cited information only and never gives medical advice.

Oncology

Zephyra®

A targeted therapy studied in advanced disease.

Neuroscience

Velocta®

For adults with relapsing forms of MS.

Cardiology

Cardil®

Cholesterol management, twice-yearly dosing.

Hematology

Hemova®

An oral therapy for a rare blood disorder.

Prescribing Information → Patient resources → Ask Medical Information →

Important Safety Information

This section would carry each medicine's full Important Safety Information — including contraindications, warnings and precautions, and the most common adverse reactions — alongside a link to the complete Prescribing Information.

Reporting a side effect? Report suspected adverse events to Meridian Drug Safety or your national reporting authority.